NORLESTRIN FE 1 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norlestrin Fe 1, and what generic alternatives are available?
Norlestrin Fe 1 is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in NORLESTRIN FE 1 is ethinyl estradiol; ferrous fumarate; norethindrone acetate. There are twenty-six drug master file entries for this compound. Additional details are available on the ethinyl estradiol; ferrous fumarate; norethindrone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORLESTRIN FE 1?
- What are the global sales for NORLESTRIN FE 1?
- What is Average Wholesale Price for NORLESTRIN FE 1?
Summary for NORLESTRIN FE 1
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | NORLESTRIN FE 1 at DailyMed |
US Patents and Regulatory Information for NORLESTRIN FE 1
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | NORLESTRIN FE 1/50 | ethinyl estradiol; ferrous fumarate; norethindrone acetate | TABLET;ORAL-28 | 016766-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
